Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.70 |
| ▸ | RAB9A | P51151 | 5/20 | 0.70 |
| ▸ | NPC1 | O15118 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.59 |
| ▸ | ELANE | P08246 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | CASP3 | P42574 | 1/20 | 0.59 |
| ▸ | HBB | P68871 | 1/20 | 0.59 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.59 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28527666 | 0.83 | SMN1; SMN2 (0.56) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL1426442 | 0.82 | SMN1; SMN2 (0.70) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL29906115 | 0.82 | SMN1; SMN2 (0.70) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL496978 | 0.82 | RAB9A (1.00) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL3182071 | 0.81 | RAB9A (0.58) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL28783594 | 0.79 | EPHX2 (0.53) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL29669840 | 0.79 | EPHX2 (0.53) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL769353 | 0.79 | ALDH1A1 (0.75) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL57336 | 0.77 | ALDH1A1 (0.67) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 | |
| SCHEMBL29501107 | 0.77 | ALDH1A1 (0.67) | SMN1; SMN2RAB9ANPC1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| US-20250346721-A1 | FOAM COMPOSITION INCLUDING SILICONE MQ RESINS AND RELATED ARTICLES AND PROCESSES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-11-13 | — | — | US | disclosed |
| EP-4532593-A1 | FOAM COMPOSITION INCLUDING SILICONE MQ RESINS AND RELATED ARTICLES AND PROCESSES | 3M Innovative Properties Company (US) | 2025-04-09 | — | — | EP | disclosed |
| CN-119421918-A | Foam compositions comprising surface-modified nanoparticles and related articles and methods | 3M创新有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119301185-A | Foam compositions comprising silicone MQ resins and related articles and methods | 3M创新有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-116057143-B | Double-sided tissue tape and related articles | 3M创新有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-117836384-A | Single layer adhesive film and related articles | 3M创新有限公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2023233379-A1 | FOAM COMPOSITION INCLUDING SILICONE MQ RESINS AND RELATED ARTICLES AND PROCESSES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023233376-A1 | FOAM COMPOSITION INCLUDING SURFACE-MODIFIED NANOPARTICLES AND RELATED ARTICLES AND PROCESSES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-07 | — | — | WO | disclosed |
| US-20150152298-A1 | PRESSURE-SENSITIVE ADHESIVES WITH MIXED PHOTOCROSSLINKING SYSTEM | 3M INNOVATIVE PROPERTIES COMPANY | 2015-06-04 | — | — | US | disclosed |
| US-8993205-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8993205-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8980967-B2 | Pressure-sensitive adhesives with mixed photocrosslinking system | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-03-17 | — | — | US | disclosed |
| EP-2702080-A1 | PRESSURE-SENSITIVE ADHESIVES WITH MIXED PHOTOCROSSLINKING SYSTEM | 3M Innovative Properties Company (US) | 2014-03-05 | — | — | EP | disclosed |
| US-20140039083-A1 | PRESSURE-SENSITIVE ADHESIVES WITH MIXED PHOTOCROSSLINKING SYSTEM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-02-06 | — | — | US | disclosed |
| WO-2012148608-A1 | PRESSURE-SENSITIVE ADHESIVES WITH MIXED PHOTOCROSSLINKING SYSTEM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-11-01 | — | — | WO | disclosed |
| US-20100129723-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-1933404-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | Mitsubishi Chemical Corporation (JP) | 2008-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | SMN1; SMN2 4118/4885RAB9A 3373/4885NPC1 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.